{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:46:18Z","timestamp":1787496378100,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) diagnosis continues to face challenges regarding the specificity and sensitivity of routine serological markers. This study aimed to assess the demographic distribution and serum biomarker profiles of RA patients with varying disease severity in Haryana, India, and to evaluate their diagnostic utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 200 participants were enrolled, including 150 RA patients and 50 healthy controls. RA patients were stratified into mild (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a050), moderate (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a050), and severe (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a050) disease categories using the Disease Activity Score-28 (DAS28). Demographic data, body mass index (BMI), and serum levels of rheumatoid factor (RF), anticyclic citrullinated peptide antibodies (anti-CCP), and C-reactive protein (CRP) were measured and statistically analyzed for intergroup comparisons and diagnostic correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Female predominance was observed across all RA severity groups, with the highest proportion in the severe category. Biomarker levels (RF, anti-CCP, and CRP) showed significant progressive elevation from mild to severe RA. Statistical analysis demonstrated robust correlations between biomarker titers and disease severity, with anti-CCP exhibiting the highest specificity among individual markers. Combined RF and anti-CCP assessment improved diagnostic accuracy. Chi-square tests revealed significant associations between biomarker profiles and disease severity, supporting their diagnostic relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings underscore the clinical significance of combining serological biomarkers to enhance diagnostic precision in RA. The graded increase in biomarker titers across severity levels suggests their potential role in disease stratification and the development of tailored therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004099","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:00:19Z","timestamp":1760605219000},"page":"8221-8228","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Categorization of rheumatoid arthritis into mild, moderate, and severe conditions to discriminate specificity and sensitivity of routine diagnostic serum biomarkers"],"prefix":"10.1097","volume":"87","author":[{"given":"Preeti","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Biochemistry, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Koundal","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel Ahmed","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Biosciences & Technology and Central Research Cell, MM Engineering College, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbaz","family":"Aman","sequence":"additional","affiliation":[{"name":"Department of Microbiology, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Bibi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, University of Asia Pacific, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"R1-20260319","doi-asserted-by":"crossref","first-page":"501\u201307","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a Brief overview of the treatment","volume":"27","author":"Bullock","year":"2018","journal-title":"Med Princ Pract"},{"key":"R2-20260319","doi-asserted-by":"crossref","first-page":"148\u201363","DOI":"10.1111\/imr.12829","article-title":"Autoantibodies and B Cells: the ABC of rheumatoid arthritis pathophysiology","volume":"294","author":"Volkov","year":"2020","journal-title":"Immunol Rev"},{"key":"R3-20260319","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01989","article-title":"Synovial tissue inflammation mediated by autoimmune T cells","volume":"10","author":"Takeuchi","year":"2019","journal-title":"Front Immunol"},{"key":"R4-20260319","first-page":"191\u2013201","article-title":"Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review","volume":"61","author":"Pulik","year":"2023","journal-title":"Rheumatology"},{"key":"R5-20260319","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/molecules24081537","article-title":"Shedding new light on the role of \u03b1\u03bd\u03b23 and \u03b15\u03b21 integrins in rheumatoid arthritis","volume":"24","author":"Morshed","year":"2019","journal-title":"Molecules"},{"key":"R6-20260319","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R7-20260319","article-title":"Etiology and risk factors for rheumatoid arthritis: a State-of-the-art review","volume":"8","author":"Rom\u00e3o","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R8-20260319","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/app12010010","article-title":"Rheumatoid arthritis diagnosis: deep learning vs","volume":"12","author":"Avramidis","year":"2021","journal-title":"Hum Appl Sci"},{"key":"R9-20260319","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3390\/ijms21114015","article-title":"Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20260319","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","article-title":"Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis","volume":"59","author":"de Brito Rocha","year":"2019","journal-title":"Adv Rheumatol"},{"key":"R11-20260319","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13075-020-02405-7","article-title":"Serum biomarker panel for the diagnosis of rheumatoid arthritis","volume":"23","author":"Mun","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R12-20260319","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R13-20260319","doi-asserted-by":"crossref","first-page":"1335\u201341","DOI":"10.3889\/oamjms.2018.246","article-title":"Detection of Biofilm Producing Staphylococci among Different Clinical Isolates and Its Relation to Methicillin Susceptibility","volume":"6","author":"Abdel Halim","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"R14-20260319","first-page":"141\u201357","article-title":"Guidelines for the diagnosis of rheumatoid arthritis","volume":"53","author":"LM","year":"2013","journal-title":"Rev Bras Reumatol (English Edition)"},{"key":"R15-20260319","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1038\/s41598-025-92150-1","article-title":"Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"R16-20260319","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/jpm12030499","article-title":"Focus on sex and gender: what we need to know in the management of rheumatoid arthritis","volume":"12","author":"Maranini","year":"2022","journal-title":"J Pers Med"},{"key":"R17-20260319","article-title":"What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis?","volume":"9","author":"Raine","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R18-20260319","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12905-025-03670-x","article-title":"Early menopause is associated with higher disease activity independent of inflammation in postmenopausal-onset rheumatoid arthritis","volume":"25","author":"Ouyang","year":"2025","journal-title":"BMC Womens Health"},{"key":"R19-20260319","doi-asserted-by":"crossref","first-page":"e003176","DOI":"10.1136\/rmdopen-2023-003176","article-title":"Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause","volume":"9","author":"Cutolo","year":"2023","journal-title":"RMD Open"},{"key":"R20-20260319","doi-asserted-by":"crossref","first-page":"696\u2013710","DOI":"10.1097\/MS9.0000000000002890","article-title":"Rheumatoid arthritis: a comprehensive overview of genetic markers, emerging therapies, and personalized medicine","volume":"87","author":"Shakeel","year":"2025","journal-title":"Ann Med Surg"},{"key":"R21-20260319","doi-asserted-by":"crossref","first-page":"1217\u201324","DOI":"10.1002\/art.40858","article-title":"Investigating asthma, allergic disease, passive smoke exposure, and risk of rheumatoid arthritis","volume":"71","author":"Kronzer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R22-20260319","doi-asserted-by":"crossref","first-page":"18325","DOI":"10.1038\/s41598-025-03464-z","article-title":"Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study","volume":"15","author":"Markovic","year":"2025","journal-title":"Sci Rep"},{"key":"R23-20260319","article-title":"Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the global burden of disease database","volume":"12","author":"Shi","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R24-20260319","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.mjafi.2020.04.007","article-title":"The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population","volume":"78","author":"Kumar","year":"2022","journal-title":"Med J Armed Forces India"},{"key":"R25-20260319","doi-asserted-by":"crossref","first-page":"1094\u2013108","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"R26-20260319","doi-asserted-by":"crossref","first-page":"733\u201345","DOI":"10.1016\/j.berh.2010.10.001","article-title":"Rheumatoid arthritis","volume":"24","author":"Carmona","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R27-20260319","doi-asserted-by":"crossref","first-page":"440\u201351","DOI":"10.1111\/1756-185X.12621","article-title":"Literature review of rheumatoid arthritis in India","volume":"19","author":"Handa","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"R28-20260319","first-page":"481\u201383","article-title":"2010 ACR-EULAR classification criteria for rheumatoid arthritis","volume":"50","author":"Villeneuve","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"R29-20260319","doi-asserted-by":"crossref","first-page":"797\u2013808","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti\u2013cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"R30-20260319","doi-asserted-by":"crossref","first-page":"155\u201363","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R31-20260319","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ijms22020686","article-title":"From rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R32-20260319","article-title":"The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis","volume":"5","author":"Orr","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R33-20260319","doi-asserted-by":"crossref","first-page":"10699\u2013709","DOI":"10.2147\/JIR.S488605","article-title":"Rheumatoid factor titer as an indicator of the risk of rheumatoid arthritis activity: dose\u2013effect analysis with the restricted cubic spline model","volume":"17","author":"Peng","year":"2024","journal-title":"J Inflamm Res"},{"key":"R34-20260319","doi-asserted-by":"crossref","first-page":"36\u201340","DOI":"10.3329\/birdem.v12i1.57223","article-title":"Anti-CCP antibody in rheumatoid arthritis patients and its relation with severity of the disease","volume":"12","author":"Yasmin","year":"2021","journal-title":"BIRDEM Med J"},{"key":"R35-20260319","doi-asserted-by":"crossref","first-page":"123\u201336","DOI":"10.1007\/s40744-024-00730-w","article-title":"High-titer rheumatoid factor is associated with worse clinical outcomes and higher needs for advanced therapies in rheumatoid arthritis under real-life conditions","volume":"12","author":"Oliveira","year":"2025","journal-title":"Rheumatol Ther"},{"key":"R36-20260319","doi-asserted-by":"crossref","first-page":"251\u201361","DOI":"10.1093\/jalm\/jfad088","article-title":"Performance of anti-carbamylated protein antibody testing in the routine evaluation of rheumatoid arthritis from a single center","volume":"9","author":"Nelson","year":"2024","journal-title":"J Appl Lab Med"},{"key":"R37-20260319","doi-asserted-by":"crossref","first-page":"3033\u201339","DOI":"10.1007\/s10067-019-04654-7","article-title":"Predictors and the optimal duration of sustained remission in rheumatoid arthritis","volume":"38","author":"Yilmaz-Oner","year":"2019","journal-title":"Clin Rheumatol"}],"updated-by":[{"DOI":"10.1097\/ms9.0000000000005368","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:03:20Z","timestamp":1773936200000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004099","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-02-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}